INTELLIA THERAPEUTICS, INC. Capital Expenditures
INTELLIA THERAPEUTICS, INC. (NTLA) reported Capital Expenditures of $1.89 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- INTELLIA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.81M, a 656.90% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $79.00K, a 89.25% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $126.00K, a 87.16% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $29.00K, a 97.73% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $1.13M, a 80.46% decline from fiscal 2024.
- INTELLIA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $5.78M, a 58.68% decline from fiscal 2023.
- INTELLIA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $13.98M, a 3.15% increase from fiscal 2022.
- INTELLIA THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $13.56M, a 6.29% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 8 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.89M 10-Q · filed 2026-08-06 | $2.01M derived: sum of 3 quarters · filed 2026-08-06 | $2.04M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $79.00K 10-Q · filed 2026-05-11 | $205.00K derived: sum of 2 quarters · filed 2026-05-11 | $234.00K derived: sum of 3 quarters · filed 2026-05-11 | $473.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $155.00K derived: sum of 2 quarters · filed 2026-02-26 | $394.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.13M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $268.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.00M 10-Q · filed 2025-11-06 | $1.98M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $239.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $974.00K 10-Q · filed 2026-08-06 | $1.96M derived: sum of 3 quarters · filed 2026-08-06 | $3.23M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $735.00K 10-Q · filed 2026-05-11 | $1.72M derived: sum of 2 quarters · filed 2026-05-11 | $3.00M derived: sum of 3 quarters · filed 2026-05-11 | $4.01M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $981.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.26M derived: sum of 2 quarters · filed 2026-02-26 | $3.27M derived: sum of 3 quarters · filed 2026-02-26 | $5.78M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.29M derived: sum of 2 quarters · filed 2025-11-06 | $4.80M 10-Q · filed 2025-11-06 | $6.32M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.52M 10-Q · filed 2025-08-07 | $5.04M derived: sum of 3 quarters · filed 2026-02-26 | $9.37M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $2.51M 10-Q · filed 2025-05-08 | $4.03M derived: sum of 2 quarters · filed 2026-02-26 | $8.36M derived: sum of 3 quarters · filed 2026-02-26 | $12.66M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.85M derived: sum of 2 quarters · filed 2026-02-26 | $10.15M derived: sum of 3 quarters · filed 2026-02-26 | $13.98M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $8.63M derived: sum of 2 quarters · filed 2024-11-07 | $12.46M 10-Q · filed 2024-11-07 | $16.38M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $8.13M 10-Q · filed 2024-08-08 | $12.04M derived: sum of 3 quarters · filed 2025-02-27 | $16.28M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $3.83M 10-Q · filed 2024-05-09 | $7.74M derived: sum of 2 quarters · filed 2025-02-27 | $11.98M derived: sum of 3 quarters · filed 2025-02-27 | $15.96M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $8.15M derived: sum of 2 quarters · filed 2025-02-27 | $12.13M derived: sum of 3 quarters · filed 2025-02-27 | $13.56M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $4.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $8.22M derived: sum of 2 quarters · filed 2023-11-09 | $9.65M 10-Q · filed 2023-11-09 | $12.51M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-06-30 | $3.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $5.41M 10-Q · filed 2023-08-03 | $8.28M derived: sum of 3 quarters · filed 2024-02-22 | $12.81M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-03-31 | $1.43M 10-Q · filed 2023-05-04 | $4.30M derived: sum of 2 quarters · filed 2024-02-22 | $8.84M derived: sum of 3 quarters · filed 2024-02-22 | $11.77M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | $2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $7.41M derived: sum of 2 quarters · filed 2024-02-22 | $10.34M derived: sum of 3 quarters · filed 2024-02-22 | $12.76M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $4.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $7.48M derived: sum of 2 quarters · filed 2022-11-03 | $9.89M 10-Q · filed 2022-11-03 | $10.89M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $2.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $5.35M 10-Q · filed 2022-08-04 | $6.36M derived: sum of 3 quarters · filed 2023-02-23 | $7.05M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $2.41M 10-Q · filed 2022-05-05 | $3.42M derived: sum of 2 quarters · filed 2023-02-23 | $4.12M derived: sum of 3 quarters · filed 2023-02-23 | $5.15M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.70M derived: sum of 2 quarters · filed 2023-02-23 | $2.74M derived: sum of 3 quarters · filed 2023-02-23 | $3.58M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $698.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.73M derived: sum of 2 quarters · filed 2021-11-04 | $2.58M 10-Q · filed 2021-11-04 | $5.15M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.88M 10-Q · filed 2021-08-05 | $4.45M derived: sum of 3 quarters · filed 2022-02-24 | $6.20M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $845.00K 10-Q · filed 2021-05-06 | $3.42M derived: sum of 2 quarters · filed 2022-02-24 | $5.17M derived: sum of 3 quarters · filed 2022-02-24 | $6.11M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $4.32M derived: sum of 2 quarters · filed 2022-02-24 | $5.26M derived: sum of 3 quarters · filed 2022-02-24 | $6.79M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.69M derived: sum of 2 quarters · filed 2020-11-05 | $4.22M 10-Q · filed 2020-11-05 | $5.81M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | $941.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.47M 10-Q · filed 2020-08-06 | $4.07M derived: sum of 3 quarters · filed 2021-02-26 | $6.08M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | $1.53M 10-Q · filed 2020-05-07 | $3.13M derived: sum of 2 quarters · filed 2021-02-26 | $5.14M derived: sum of 3 quarters · filed 2021-02-26 | $6.04M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $3.61M derived: sum of 2 quarters · filed 2021-02-26 | $4.51M derived: sum of 3 quarters · filed 2021-02-26 | $6.36M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $2.92M derived: sum of 2 quarters · filed 2019-10-31 | $4.77M 10-Q · filed 2019-10-31 | $7.16M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $2.75M 10-Q · filed 2019-08-01 | $5.15M derived: sum of 3 quarters · filed 2020-02-27 | $7.41M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $1.85M 10-Q · filed 2019-05-02 | $4.25M derived: sum of 2 quarters · filed 2020-02-27 | $6.51M derived: sum of 3 quarters · filed 2020-02-27 | $7.78M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $4.66M derived: sum of 2 quarters · filed 2020-02-27 | $5.93M derived: sum of 3 quarters · filed 2020-02-27 | $10.09M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $3.53M derived: sum of 2 quarters · filed 2018-10-31 | $7.69M 10-Q · filed 2018-10-31 | $11.10M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $5.43M 10-Q · filed 2018-08-01 | $8.84M derived: sum of 3 quarters · filed 2019-02-27 | $9.44M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | $4.16M 10-Q · filed 2018-05-01 | $7.57M derived: sum of 2 quarters · filed 2019-02-27 | $8.17M derived: sum of 3 quarters · filed 2019-02-27 | $9.32M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $4.01M derived: sum of 2 quarters · filed 2019-02-27 | $5.16M derived: sum of 3 quarters · filed 2019-02-27 | $6.17M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $605.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $1.75M derived: sum of 2 quarters · filed 2017-10-31 | $2.76M 10-Q · filed 2017-10-31 | $3.61M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $2.15M 10-Q · filed 2017-08-01 | $3.00M derived: sum of 3 quarters · filed 2018-03-14 | $3.61M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-03-31 | $1.01M 10-Q · filed 2017-05-02 | $1.86M derived: sum of 2 quarters · filed 2018-03-14 | $2.46M derived: sum of 3 quarters · filed 2018-03-14 | $3.05M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2015-12-31 | $849.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $1.45M derived: sum of 2 quarters · filed 2018-03-14 | $2.04M derived: sum of 3 quarters · filed 2018-03-14 | $2.55M 10-K · filed 2018-03-14 | |
| 2015-09-30 | $602.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $1.19M derived: sum of 2 quarters · filed 2016-11-01 | $1.71M 10-Q · filed 2016-11-01 | ||
| 2015-06-30 | $587.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.10M 10-Q · filed 2016-08-04 | |||
| 2015-03-31 | $516.00K 10-Q · filed 2016-06-03 | ||||
| 2014-12-31 | $275.00K 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |